Gengo Sunagawa

ORCID: 0000-0003-4852-0702
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mechanical Circulatory Support Devices
  • Transplantation: Methods and Outcomes
  • Cardiac Structural Anomalies and Repair
  • Cardiac Arrest and Resuscitation
  • Cardiac Valve Diseases and Treatments
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Organ and Tissue Transplantation Research
  • Tracheal and airway disorders
  • Organ Transplantation Techniques and Outcomes
  • Cardiac pacing and defibrillation studies
  • Congenital Heart Disease Studies
  • Cardiac Arrhythmias and Treatments
  • Infective Endocarditis Diagnosis and Management
  • Cardiac and Coronary Surgery Techniques
  • Renal Transplantation Outcomes and Treatments
  • Pulmonary Hypertension Research and Treatments
  • Aortic Disease and Treatment Approaches
  • Cardiovascular Function and Risk Factors
  • Medical Imaging and Pathology Studies
  • Atrial Fibrillation Management and Outcomes
  • Polyomavirus and related diseases
  • Fuel Cells and Related Materials
  • Cardiac Imaging and Diagnostics
  • Cardiac tumors and thrombi
  • Aortic Thrombus and Embolism

Rutgers, The State University of New Jersey
2022-2024

Johnson University
2022-2024

Temple University
2018-2023

Robert Wood Johnson University Hospital
2023

Temple University Hospital
2018-2022

Cleveland Clinic Lerner College of Medicine
2014-2021

Medical University of Vienna
2021

University Medical Center
2021

Cleveland Clinic
2015-2017

OSRAM (United States)
2015

Cleveland Clinic's continuous-flow total artificial heart (CFTAH) provides systemic and pulmonary circulations using one assembly (one motor, two impellers). The right pump hydraulic output to the circulation is self-regulated by rotating assembly's passive axial movement in response atrial differential pressure balance itself left output. This combination of features integrates a biocompatible, pressure-balancing regulator with double-ended pump. CFTAH requires no flow or sensors. only...

10.1111/aor.12780 article EN Artificial Organs 2016-07-12

Implantation of mechanical circulatory support devices is challenging, especially in patients with a small chest cavity. We evaluated how well the Cleveland Clinic continuous-flow total artificial heart (CFTAH) fit anatomy about to receive transplant. A mock pump model CFTAH was rapid-prototyped using biocompatible materials. The brought operative table, and direction, length, angulation inflow/outflow ports outflow conduits were after recipient's ventricles had been resected. Thoracic...

10.1097/mat.0000000000000219 article EN ASAIO Journal 2015-03-25

Abstract OBJECTIVES Mechanical circulatory support has become standard therapy for adult patients with end-stage heart failure; however, in paediatric congenital disease, the options chronic mechanical are limited to paracorporeal devices or off-label use of intended implantation adults. Congenital disease and cardiomyopathy often involve both left right ventricles; such cases, transplantation, a biventricular assist device total artificial is needed adequately sustain pulmonary systemic...

10.1093/icvts/ivx429 article EN Interactive Cardiovascular and Thoracic Surgery 2017-12-20

Control of mechanical circulatory support pump output typically requires that pressure-regulating functions be accomplished by active control the speed or geometry device, with feedback from pressure flow sensors. This article presents a different design approach, device as core feature, allowing essential function regulating to directly programmed into hydromechanical design. We show step-by-step transformation continuous-flow total artificial heart passively balances left and right...

10.1097/mat.0000000000000772 article EN ASAIO Journal 2018-03-14

Abstract The choice of optimal operative access technique for mechanical circulatory support device implantation ensures successful postoperative outcomes. In this study, we retrospectively evaluated the median sternotomy and lateral thoracotomy incisions placement C leveland linic continuous‐flow total artificial heart ( CFTAH ) in a bovine model. was implanted 17 calves J ersey calves; weight range, 77.0–93.9 kg) through n = 9) or right 8) elective chronic periods 14, 30, 90 days. Similar...

10.1111/aor.12660 article EN Artificial Organs 2015-12-18

Abstract The V entri F lo True Pulse Pump (Design Mentor, Inc., Pelham, NH, USA) is the first blood pump designed to mimic human arterial waveforms in a standard oxygenation circuit. Our aim was demonstrate feasibility and safety of this preparation for future studies determine possible clinical advantages. We studied four piglets (41.4–46.2 kg): three with an implanted pulsatile one nonpulsatile ROTAFLOW (MAQUET Holding B.V. & Co. KG, Rastatt, Germany) as control. Hemodynamics monitored...

10.1111/aor.12986 article EN Artificial Organs 2017-10-27

Debate continues on whether a bilateral (BLT) or single lung transplantation (SLT) is preferred for patients with end-stage chronic obstructive pulmonary disease (COPD). The purpose of this study to examine the interplay between patient age and transplant type survival outcomes.We performed retrospective transplants COPD at our centre from February 2012 March 2020 (n = 186). Demographics clinical parameters were compared based their (≤65 vs >65 years old) (single bilateral). Cox proportional...

10.1093/icvts/ivab169 article EN public-domain Interactive Cardiovascular and Thoracic Surgery 2021-05-18
Coming Soon ...